These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1967563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Histological and neurochemical effects of fetal treatment with methylazoxymethanol on rat neocortex in adulthood.
    Johnston MV, Coyle JT.
    Brain Res; 1979 Jul 06; 170(1):135-55. PubMed ID: 37983
    [Abstract] [Full Text] [Related]

  • 3. Methylazoxymethanol-induced microencephaly: persistent increase of cortical somatostatin-like immunoreactivity.
    Cattabeni F, Abbracchio MP, Cimino M, Cocchi D, Di Luca M, Mennuni L, Rosi F, Zaratin P.
    Brain Res Dev Brain Res; 1989 May 01; 47(1):156-9. PubMed ID: 2736763
    [Abstract] [Full Text] [Related]

  • 4. Effects of prenatal methylazoxymethanol treatment on the development of central monoamine neurons.
    Jonsson G, Hallman H.
    Brain Res; 1981 Nov 01; 254(4):513-30. PubMed ID: 6118203
    [Abstract] [Full Text] [Related]

  • 5. Ganglion cells immunoreactive for catecholamine-synthesizing enzymes, neuropeptide Y and vasoactive intestinal polypeptide in the rat adrenal gland.
    Oomori Y, Okuno S, Fujisawa H, Iuchi H, Ishikawa K, Satoh Y, Ono K.
    Cell Tissue Res; 1994 Feb 01; 275(2):201-13. PubMed ID: 7906614
    [Abstract] [Full Text] [Related]

  • 6. Effects of transient forebrain ischemia on peptidergic neurons and astroglial cells: evidence for recovery of peptide immunoreactivities in neocortex and striatum but not hippocampal formation.
    Grimaldi R, Zoli M, Agnati LF, Ferraguti F, Fuxe K, Toffano G, Zini I.
    Exp Brain Res; 1990 Feb 01; 82(1):123-36. PubMed ID: 1979543
    [Abstract] [Full Text] [Related]

  • 7. Microencephalic rats as a model for cognitive disorders.
    Balduini W, Cimino M, Lombardelli G, Abbracchio MP, Peruzzi G, Cecchini T, Gazzanelli GC, Cattabeni F.
    Clin Neuropharmacol; 1986 Feb 01; 9 Suppl 3():S8-18. PubMed ID: 3594461
    [Abstract] [Full Text] [Related]

  • 8. Persistent innervation of the rat neocortex by basal forebrain cholinergic neurons despite the massive reduction of cortical target neurons. I. Morphometric analysis.
    Minger SL, Davies P.
    Exp Neurol; 1992 Aug 01; 117(2):124-38. PubMed ID: 1499691
    [Abstract] [Full Text] [Related]

  • 9. Developmental alteration of serotonin neurons in the raphe nucleus of rats with methylazoxymethanol-induced microcephaly.
    Funahashi A, Inouye M, Yamamura H.
    Acta Neuropathol; 1992 Aug 01; 85(1):31-8. PubMed ID: 1285494
    [Abstract] [Full Text] [Related]

  • 10. NPY-, galanin-, VIP/PHI-, CGRP- and substance P-immunoreactive neuronal subpopulations in cat autonomic and sensory ganglia and their projections.
    Lindh B, Lundberg JM, Hökfelt T.
    Cell Tissue Res; 1989 Aug 01; 256(2):259-73. PubMed ID: 2471596
    [Abstract] [Full Text] [Related]

  • 11. Direct and indirect effects on the lateral geniculate nucleus neurons of prenatal exposure to methylazoxymethanol acetate.
    Ashwell K.
    Brain Res; 1987 Oct 01; 432(2):199-214. PubMed ID: 3676837
    [Abstract] [Full Text] [Related]

  • 12. Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions.
    Seroogy KB, Dangaran K, Lim S, Haycock JW, Fallon JH.
    J Comp Neurol; 1989 Jan 15; 279(3):397-414. PubMed ID: 2563737
    [Abstract] [Full Text] [Related]

  • 13. Vascularity and cytochrome oxidase distribution in the occipital cortex in MAM Ac-induced micrencephaly.
    Ashwell KW, Webster WS.
    Brain Res; 1987 Jun 15; 430(2):301-4. PubMed ID: 3038275
    [Abstract] [Full Text] [Related]

  • 14. Selective attention and place navigation in rats treated prenatally with methylazoxymethanol.
    Mohammed AK, Jonsson G, Sundström E, Minor BG, Söderberg U, Archer T.
    Brain Res; 1986 Dec 15; 395(2):145-55. PubMed ID: 3640654
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hyperactivity and instrumental learning deficits in methylazoxymethanol-treated rat offspring.
    Archer T, Hiltunen AJ, Järbe TU, Kamkar MR, Luthman J, Sundström E, Teiling A.
    Neurotoxicol Teratol; 1988 Dec 15; 10(4):341-7. PubMed ID: 3226377
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Methylazoxymethanol as a developmental model of neurotoxicity.
    Kabat K, Buterbaugh GG, Eccles CU.
    Neurobehav Toxicol Teratol; 1985 Dec 15; 7(5):519-25. PubMed ID: 4080069
    [Abstract] [Full Text] [Related]

  • 20. Further analysis of presence of peptides in dopamine neurons. Cholecystokinin, peptide histidine-isoleucine/vasoactive intestinal polypeptide and substance P in rat supramammillary region and mesencephalon.
    Seroogy K, Tsuruo Y, Hökfelt T, Walsh J, Fahrenkrug J, Emson PC, Goldstein M.
    Exp Brain Res; 1988 Dec 15; 72(3):523-34. PubMed ID: 2466680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.